{
  "ticker": "LLY",
  "target_date": "2025-04-01",
  "actual_date": "2025-04-01",
  "collected_at": "2025-12-08T11:35:15.296365",
  "price": {
    "open": 813.94,
    "high": 815.99,
    "low": 792.46,
    "close": 800.6458740234375,
    "volume": 2987700,
    "change_1d_pct": -2.5,
    "change_7d_pct": -3.86,
    "change_30d_pct": -6.06
  },
  "technicals": {
    "rsi_14": 44.99,
    "sma_20": 834.55,
    "sma_50": 840.13,
    "macd": -9.318,
    "macd_signal": -5.645,
    "macd_histogram": -3.673,
    "bb_upper": 900.08,
    "bb_lower": 769.03,
    "price_vs_sma20_pct": -4.06,
    "price_vs_sma50_pct": -4.7,
    "volume_ratio": 0.87
  },
  "fundamentals": {
    "market_cap": 889464422400,
    "pe_ratio": 48.613426,
    "forward_pe": 43.786407,
    "price_to_book": 37.35693,
    "price_to_sales": 14.969159,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.77,
    "pct_from_52w_low": 59.06
  },
  "macro": {
    "spy": {
      "price": 557.77,
      "change_1d_pct": 0.28,
      "change_7d_pct": -2.28
    },
    "vix": {
      "level": 21.77,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.16
    },
    "dollar_index": {
      "level": 104.26
    },
    "gold": {
      "price": 3118.9
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Hims & Hers Expands Weight Loss Offering, Adds Lilly\u2019s Zepbound to Platform",
      "source": "Yahoo",
      "datetime": 1743550680,
      "summary": "Hims & Hers Health  said it is expanding its weight-loss offerings with the addition of  Eli Lilly  & Co. Zepbound and generic liraglutide.  The telehealth-consultation platform on Tuesday said it aimed to bring its customers more treatment options to best suit their needs.  \u201cWe\u2019ve now expanded that",
      "url": "https://finnhub.io/api/news?id=eefdfe9c27a794d1da174d4d96141ac9b8d70b207e28c54c519d26cc598eb518"
    },
    {
      "headline": "Hims & Hers Stock Surges as Telehealth Platform Adds Eli Lilly Weight-Loss Drugs",
      "source": "Yahoo",
      "datetime": 1743543488,
      "summary": "Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly\u2019s weight-loss drug Zepbound and diabetes treatment Mounjaro to its telehealth platform.",
      "url": "https://finnhub.io/api/news?id=e6b49f1119274156eaae4fb1b2f7d471270564dafa6c2021ad0ad101b170a933"
    },
    {
      "headline": "Eli Lilly and Company (LLY): The Best Healthcare Stock to Buy According to Billionaires",
      "source": "Yahoo",
      "datetime": 1743541149,
      "summary": "We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging year in 2024, laggi",
      "url": "https://finnhub.io/api/news?id=c056e161078cf9ceea195a3b699ca0af7593241ff7c97f66930f8683c663b08c"
    },
    {
      "headline": "Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback",
      "source": "Yahoo",
      "datetime": 1743540527,
      "summary": "Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to discuss some of the top stories of the trading day, including Johnson & Johnson's (JNJ) setback in its litigation. Additionally, Hims & Hers (HIMS) expanded its offerings, adding Eli Lilly's (LLY) GLP-1 drugs to its telehealth",
      "url": "https://finnhub.io/api/news?id=16c699b332de57394a58b8070aba6ae3a3bec745ff109be2aa73ba7125a2e757"
    },
    {
      "headline": "Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform",
      "source": "Yahoo",
      "datetime": 1743538516,
      "summary": "Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its telehealth platform.",
      "url": "https://finnhub.io/api/news?id=53c3a03eff706b7ad16a906ef211df0bea2b8da20015bab4eb49fde725f274ee"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742416067.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000103/xslF345X05/wk-form4_1742416067.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415936.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000101/xslF345X05/wk-form4_1742415936.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415842.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000099/xslF345X05/wk-form4_1742415842.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415665.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000097/xslF345X05/wk-form4_1742415665.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415462.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000095/xslF345X05/wk-form4_1742415462.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}